ADIPOSE, BRAIN OR LIVER? EVALUATING TISSUE SELECTION FOR DETECTING BROMETHALIN EXPOSURE IN WILDLIFE

Ryan P Bourbour; California Department of Fish and Wildlife; ryan.bourbour@wildlife.ca.gov; Molly Jarrells, Jordan Langley, Brandon Munk, Robert Poppenga, Deana Clifford

Bromethalin is a neurotoxic rodenticide that can affect non-target wildlife and has increased in usage following statewide anticoagulant rodenticide restrictions. Detection of its bioactive metabolite, desmethylbromethalin (DMB), documents bromethalin exposure and can help support a diagnosis of intoxication in wildlife species. However, tissue-specific differences in DMB detection may affect interpretations of wildlife toxicology results. To evaluate differences, we compared DMB concentrations in paired adipose (fat), brain, and/or liver tissues from wild mammals with an initial DMB detection. All tissues were analyzed using validated methods with equivalent reporting limits. DMB was frequently quantifiable in adipose when paired brain or liver samples contained trace or nondetectable concentrations. In some animals, adipose DMB concentrations of hundreds to thousands of ng/g corresponded with trace or nondetectable results in paired tissues. Additionally, trace detection in adipose consistently corresponded with nondetectable DMB concentrations in brain or liver. These findings indicate that adipose tissue is a more reliable matrix for DMB detection than brain or liver. Although brain and liver are alternative matrices, nondetection in these tissues does not exclude bromethalin exposure or toxicosis. Our findings highlight the importance of tissue selection in wildlife mortality investigations and exposure surveillance.

Poster Session A  

Speaker Bio:

Ryan is a wildlife ecologist working as a Senior Environmental Scientist (Specialist) with the Wildlife Health Laboratory of California Department of Fish and Wildlife. His research interests include migration ecology, foraging ecology, and ecotoxicology.